fluconazole has been researched along with ethyl caffeate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Costi, R; D'Auria, FD; De Vita, D; Di Santo, R; Friggeri, L; Palamara, AT; Pandolfi, F; Panella, S; Piccoli, F; Scipione, L; Simonetti, G; Tortorella, S | 1 |
| Cheng, T; Li, N; Pan, M; Shao, J; Wang, Q; Wang, T; Wu, D; Wu, J; Xiao, N; Yan, G | 1 |
| Bao, M; Bu, Q; Li, N; Pan, M; Shao, J; Wang, C; Wang, T; Yang, R; Yang, Y | 1 |
3 other study(ies) available for fluconazole and ethyl caffeate
| Article | Year |
|---|---|
Activity of caffeic acid derivatives against Candida albicans biofilm.
Topics: Antifungal Agents; Biofilms; Caffeic Acids; Candida albicans; Cell Line, Tumor; Cell Survival; Humans; Microbial Sensitivity Tests | 2014 |
In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis.
Topics: Animals; Antifungal Agents; Caffeic Acids; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Mice; Virulence Factors | 2021 |
Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway.
Topics: Animals; Antifungal Agents; Azoles; Caffeic Acids; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; ErbB Receptors; Fluconazole; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Signal Transduction | 2023 |